LataMed AI Corp. (OTC: LMED), a development-stage digital health and artificial intelligence technology company, announced today that management has commenced preliminary due diligence and strategic planning for the company's expansion into Colombia. The initiative marks a key step in LataMed's broader Latin American growth strategy, focusing on building telehealth infrastructure, healthcare analytics, and care coordination solutions for emerging markets.
The initial phase includes evaluating corporate, regulatory, legal, operational, and commercial requirements for establishing a Colombian operating subsidiary. This assessment will support the future deployment of LataMed's digital healthcare platform within the Colombian market. Management believes Colombia represents an attractive long-term opportunity as the company continues to advance its regional expansion.
The ongoing review process is expected to cover corporate formation, regulatory compliance, healthcare technology implementation, strategic partnerships, and local operational infrastructure. The company noted that the evaluation aims to build upon its growing healthcare ecosystem by identifying opportunities to expand access to telehealth, healthcare coordination technologies, digital healthcare services, insurance accessibility, pharmacy integration, payment solutions, and artificial intelligence-driven healthcare technologies across additional Latin American markets.
Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI Corp., stated: "Colombia represents an important strategic opportunity as we continue executing our long-term vision of building an integrated digital healthcare ecosystem across Latin America. While we remain in the early stages of evaluating market entry requirements, we believe it is important to establish the proper legal, operational, and strategic foundation before expanding into new jurisdictions."
The company emphasized that the Colombia expansion initiative remains in the preliminary planning and due diligence stage. Management intends to complete the required corporate, regulatory, and operational review before proceeding with establishing a Colombian subsidiary. Further updates will be provided as material developments occur.
Management believes that the continued expansion of digital healthcare infrastructure throughout Latin America presents significant opportunities to improve healthcare accessibility, strengthen patient engagement, and support technology-enabled healthcare delivery across underserved markets. LataMed's strategy centers on developing technology platforms designed to support healthcare access, patient engagement, provider coordination, emergency medical response, pharmacy integration, insurance accessibility, payment solutions, and data-driven healthcare operations.
For additional information, visit https://latamed.ai or review the company's filings with the U.S. Securities and Exchange Commission at www.sec.gov.
